Fennec Pharmaceuticals FENC
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 6.15 | -57.21 | 0.01 | -119 | 0 | |
| 2025Q4 | 7.7 | 58.4 | -0.16 | -2,554 | -5 | |
| 2025Q3 | 9.36 | 368.63 | -0.02 | -188 | -1 | |
| 2025Q2 | 8.3 | 106.8 | -0.12 | -2,732 | -3 | |
| 2025Q1 | 6.09 | 141.01 | -0.04 | -808 | -1 | |
| 2024Q4 | 6.32 | 142.81 | -0.08 | -934 | -2 | |
| 2024Q3 | 5 | 110.45 | 49.96 | -0.18 | -5,202 | -6 |
| 2024Q2 | 6.11 | 111.75 | 58.23 | -0.17 | -5,039 | -6 |
| 2024Q1 | 11.12 | 99.08 | 0.41 | 13,743 | 13 | |
| 2023Q4 | 11.22 | 102.89 | -0.1 | -1,818 | -3 | |
| 2023Q3 | 7.51 | 100.59 | -0.07 | -1,017 | -2 | |
| 2023Q2 | 8.83 | 101.02 | -0.2 | -4,666 | -5 | |
| 2023Q1 | 8.32 | 100.3 | -0.23 | -5,270 | -6 | |
| 2022Q4 | 9.6 | 100.36 | -0.25 | -6,135 | -7 | |
| 2022Q3 | 8.1 | 99.11 | -0.31 | -7,899 | -8 | |
| 2022Q2 | 5.58 | 99.88 | -0.2 | -5,009 | -5 | |
| 2022Q1 | 5.6 | 97.47 | -0.14 | -3,546 | -4 | |
| 2021Q4 | 4.4 | 96.38 | -0.17 | -4,207 | -4 | |
| 2021Q3 | 9.42 | 101.04 | -0.16 | -4,173 | -4 | |
| 2021Q2 | 7.29 | 98.1 | -0.16 | -3,920 | -4 |